Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Non Squamous NSCLC”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Looking for participantsNCT07405086
What this trial is testing

Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

Who this might be right for
Advanced Biliary Tract CarcinomaAdvanced Head and Neck Squamous Cell CarcinomaAdvanced Hepatocellular Carcinoma+18 more
OHSU Knight Cancer Institute 160
Testing effectiveness (Phase 2)Active Not RecruitingNCT06933329
What this trial is testing

Zelenectide Pevedotin in NECTIN4 Amplified Advanced or Metastatic Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
BicycleTx Limited 73
Not applicableStudy completedNCT01614002
What this trial is testing

A Non Interventional Study With Doce Onkovis (Docetaxel) Utilized for the Treatment of Cancer

Who this might be right for
Carcinoma
Onkovis GmbH 371
Early research (Phase 1)Study completedNCT02635672
What this trial is testing

Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer

Who this might be right for
Neoplasms
Vincerx Pharma, Inc. 110
Not applicableUnknownNCT00242983
What this trial is testing

Quality of Life in Patients Who Are Receiving Either Vinorelbine, Gemcitabine, and Docetaxel or Paclitaxel and Carboplatin for Advanced Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
National Hospital Organization Kinki-chuo Chest Medical Center
Testing effectiveness (Phase 2)Study completedNCT01042288
What this trial is testing

Carboplatin, Pemetrexed, and Panitumumab in Patients With Advanced Non-Squamous K-ras Wild Type NSCLC

Who this might be right for
Non-Small-Cell Lung Cancer
SCRI Development Innovations, LLC 70
Testing effectiveness (Phase 2)Looking for participantsNCT07169734
What this trial is testing

Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors

Who this might be right for
Cervical Squamous Cell CarcinomaSquamous Non-small-cell Lung CancerColorectal Cancer+2 more
Alentis Therapeutics AG 180
Testing effectiveness (Phase 2)Active Not RecruitingNCT04180371
What this trial is testing

Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression

Who this might be right for
Advanced Solid Tumor Historically Known for High EphA2 ExpressionUrothelial CancerOvarian Cancer+4 more
BicycleTx Limited 288
Testing effectiveness (Phase 2)Looking for participantsNCT06868836
What this trial is testing

Phase II Clinical Study of JS207 (PD-1/VEGF Bispecific Antibody) Combination Therapies in Patients With Driver Gene-Positive, Advanced Non-Small Cell Lung Cancer After Failure of TKI Therapy

Who this might be right for
Non-squamous Non-small Cell Lung Cancer
Shanghai Junshi Bioscience Co., Ltd. 78
Testing effectiveness (Phase 2)Study completedNCT02328105
What this trial is testing

LCI-LUN-ABR-001: Carbo With Nab-Paclitaxel in Patients With Advanced NSCL Cancer

Who this might be right for
Lung Cancer
Wake Forest University Health Sciences 11
Large-scale testing (Phase 3)Looking for participantsNCT06930794
What this trial is testing

Vebreltinib and Platinum-Containing Double Agents in Subjects With MET-Positive

Who this might be right for
Non-Small Cell Lung Cancer
Beijing Pearl Biotechnology Limited Liability Company 300
Large-scale testing (Phase 3)Ended earlyNCT03515629
What this trial is testing

REGN2810 (Anti-PD-1 Antibody), Platinum-based Doublet Chemotherapy, and Ipilimumab (Anti-CTLA-4 Antibody) Versus Pembrolizumab Monotherapy in Patients With Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Regeneron Pharmaceuticals 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT05756972
What this trial is testing

PM8002 (Anti-PD-L1/VEGF) in Combination With Chemotherapy in Patients With NSCLC

Who this might be right for
NSCLC
Biotheus Inc. 64
Testing effectiveness (Phase 2)UnknownNCT03810872
What this trial is testing

An Explorative Study of Afatinib in the Treatment of Advanced Cancer Carrying an EGFR, a HER2 or a HER3 Mutation

Who this might be right for
Cancers Harbouring an EGFR Mutation, (Excluding Non-squamous Non- Small Cell Lung Cancer, a Registered Indication), a HER2 Mutation or a HER3 Mutation
Universitair Ziekenhuis Brussel 87
Testing effectiveness (Phase 2)Study completedNCT02186847
What this trial is testing

Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer

Who this might be right for
Adenosquamous Lung CarcinomaBronchioloalveolar CarcinomaLarge Cell Lung Carcinoma+6 more
NRG Oncology 170
Early research (Phase 1)Looking for participantsNCT07638891
What this trial is testing

HDM2020 in Patients With Advanced Sq-NSCLC

Who this might be right for
Squamous Non-small Cell Lung Cancer(NSCLC)
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 150
Testing effectiveness (Phase 2)Looking for participantsNCT06975410
What this trial is testing

Clinical Trial of YH32364 in Patients With Locally Advanced or Metastatic EGFR Overexpressing Solid Tumors

Who this might be right for
EGFR OverexpressionLocally Advanced Solid TumorMetastatic Solid Tumor
Yuhan Corporation 80
Testing effectiveness (Phase 2)Ended earlyNCT02554812
What this trial is testing

Avelumab In Combination With Other Cancer Immunotherapies In Advanced Malignancies (JAVELIN Medley)

Who this might be right for
Advanced Cancer
Pfizer 409
Early research (Phase 1)Looking for participantsNCT06545331
What this trial is testing

Study of XB010 in Subjects With Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid TumorsEsophageal Squamous Cell CancerHead and Neck Squamous Cell Cancer+3 more
Exelixis 396
Testing effectiveness (Phase 2)UnknownNCT03750916
What this trial is testing

Anlotinib Combined With Docetaxel for Advanced Non-squamous Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Qilu Hospital of Shandong University 46
Next Page